Spaulding Clinical Receives FDA 510(k) Clearance for 12-Lead ECG Device

Press Release:

Spaulding Electrocardiograph 2100iQ

Spaulding Medical, LLC announced the FDA 510(k) Clearance for their newest 12-Lead ECG device - the Spaulding Electrocardiograph 2100iQ™.

The wireless, hand-held cardiac safety medical device was designed to streamline and improve the collection of real-time data of ECG data via Bluetooth™ for doctors and patients. 

Managed entirely in the Cloud, the Spaulding Electorcardiograph 2100iQ™ mission is to deliver high-quality data in less time and at a reduced cost.

With the FDA 510(k) Clearance ready, Spaulding Clinical Research, LLC has strengthened their commitment to being an innovation leader in cardiac safety solutions.


Read Full Press Release >>